MGROF:OTC-Mustgrow Biologics Corp (USD)

COMMON STOCK | Agricultural Inputs |

Last Closing

USD 0.95

Change

0.00 (0.00)%

Market Cap

USD 0.05B

Volume

8.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard seeds. It provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. The company also offers TerraMG, a mustard-derived soil biopesticide technology. In addition, it is developing TerraSante, an organic soil amendment and biofertility technology. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-21 )

Largest Industry Peers for Agricultural Inputs

Symbol Name Price(Change) Market Cap
YRAIF Yara International ASA

N/A

USD 7.64B
KPLUF K&S AG

-0.06 (-0.45%)

USD 2.48B
KNKZF KWS SAAT SE & Co. KGaA

N/A

USD 2.10B
BWEL Boswell J G Co

-9.95 (-1.78%)

USD 0.54B
MBCF Itafos Inc

-0.03 (-1.89%)

USD 0.27B
CHYI Chykingyoung Investment Develo..

-0.05 (-25.00%)

USD 0.20B
VRDR Verde Resources Inc

N/A

USD 0.19B
EDNSF Eden Research plc

N/A

USD 0.04B
VNPKF Verde Agritech Ltd.

N/A

USD 0.03B
PUBC PureBase Corp

N/A

USD 0.02B

ETFs Containing MGROF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Agricultural Inputs) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.81% 50% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.81% 50% F 50% F
Trailing 12 Months  
Capital Gain -8.65% 63% D 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.65% 56% F 43% F
Trailing 5 Years  
Capital Gain 106.52% 92% A 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 106.52% 92% A 85% B
Average Annual (5 Year Horizon)  
Capital Gain 115.42% 86% B+ 85% B
Dividend Return 115.42% 86% B+ 84% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 261.38% 14% F 20% F
Risk Adjusted Return 44.16% 89% A- 80% B-
Market Capitalization 0.05B 70% C- 52% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.